T Cell Treatment To start Trials

A Scottish biotechnology firm said it would start clinical trials on a possible T cell treatment for COVID-19, aimed at reducing the need for intensive care among hospitalized patients. T cells are white blood cells that form a key part of the immune system, along with antibodies.